HR 2071 United States House · 117th Congress

Medicare Prescription Drug Price Negotiation Act of 2021

Summary

Medicare Prescription Drug Price Negotiation Act of 2021 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Mar 2021

Committee Review

Floor Vote

President

Introduced Mar 18, 2021 Last action Mar 19, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 19, 2021

Committee

Referred to the Subcommittee on Health.

lower

Mar 18, 2021

Committee

Referred to the Subcommittee on Health.

lower

Mar 18, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Mar 18, 2021

Introduced

Introduced in House

lower

1 primary · 12 co-sponsors